Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Not yet recruiting	Phase 2	2025-07-29		NCT07007780

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Xijing Hospital	177

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials